Fingerprint
Dive into the research topics of 'Phase 1b study of berzosertib and cisplatin in patients with advanced triple-negative breast cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase 1b study of berzosertib and cisplatin in patients with advanced triple-negative breast cancer
Melinda L. Telli, Sara M. Tolaney, Geoffrey I. Shapiro, Mark Middleton, Simon R. Lord, Hendrik Tobias Arkenau, Andrew Tutt, Vandana Abramson, Emma Dean, Tufia C. Haddad, Robert Wesolowski, Jordi Ferrer-Playan, Thomas Goddemeier, Thomas Grombacher, Jennifer Dong, Patricia Fleuranceau-Morel, Ivan Diaz-Padilla, Ruth Plummer
Research output: Contribution to journal › Article › peer-review